Journal of the American College of Cardiology

publication venue for

A rare case of cardiac hemangioma causing ventricular fibrillation. 2013
Cardiac sarcoidosis. 2013
A worrisome interventricular septum: more than meets the eye. 2011
A case of all 3 coronary to bronchial arteries fistulas. 2011
Percutaneous paravalvular repair: guidance using live 3-dimensional transesophageal echocardiography. 2009
Hemodynamic compromise (tricuspid stenosis and insufficiency) caused by an unruptured aneurysm of the sinus of Valsalva. 1986
Importance of pacing site in entrainment of ventricular tachycardia. 1985
Severe Takayasu's arteritis of the pulmonary arteries: report of a case with successful surgical treatment. 1985
Cardiac echinococcal cyst: diagnosis by two-dimensional echocardiography. 1983
Coronary Artery Bypass Grafting After Acute Myocardial Infarction With Cardiogenic Shock: Analysis of the Society of Thoracic Surgeons Adult Cardiac Surgery Database. 2026
Effect of Low-Carbohydrate and Low-Fat Diets on Metabolomic Indices and Coronary Heart Disease in U.S. Individuals. 2026
Behavioral Economics and Medication Adherence for Hypertension: A Randomized Clinical Trial. 2025
Multicenter Study on the Safety of Pulsed Field Ablation in Over 40,000 Patients: MANIFEST-US. 2025
Lipoprotein(a) Levels and Time to Cardiovascular Benefit With Alirocumab in Patients With Recent Acute Coronary Syndrome.. 86. 2025
Clonal Hematopoiesis and Cardiovascular Outcomes in Older Women. 2025
Effect of Vericiguat on Worsening Heart Failure in Compensated Outpatients with HFrEF: Insights from VICTOR. 2025
Effect of Microaxial Flow Pump on Hemodynamics in STEMI-Related Cardiogenic Shock.. 85. 2025
Signaling 101 for Cardiovascular Disease Fellowship Recruitment.. 86. 2025
Disentangling the Impact of Adiposity From Insulin Resistance in Heart Failure With Preserved Ejection Fraction.. 85. 2025
Pulsed Field Ablation for Persistent Atrial Fibrillation: 1-Year Results of ADVANTAGE AF.. 85. 2025
Major Bleeding and Mortality After Revascularization of Left Main Disease.. 84. 2024
The Coming AI Revolution in Clinical Trials.. 85. 2024
The Association of Hospital-Cardiologist Integration With Patient Outcomes, Care Quality, and Utilization.. 85. 2024
Randomized Comparison of Novel Low-Dose Sirolimus-Eluting Biodegradable Polymer Stent vs Second-Generation DES: TARGET-IV NA Trial.. 85. 2024
Transcatheter Aortic Valve Replacement in Patients With Systolic Heart Failure and Moderate Aortic Stenosis: TAVR UNLOAD.. 85. 2024
Clinical Implications of Pretest Probability of HFpEF on Outcomes in Precapillary Pulmonary Hypertension. 2024
Triglyceride Levels, Alirocumab Treatment, and Cardiovascular Outcomes After an Acute Coronary Syndrome.. 84. 2024
ApoA-I Infusions and Burden of Ischemic Events After Acute Myocardial Infarction: Insights From the AEGIS-II Trial.. 84. 2024
Coronary Artery Bypass Graft Failure in Women: Incidence and Clinical Implications.. 84. 2024
Limb Outcomes With Ticagrelor Plus Aspirin in Patients With Diabetes Mellitus and Atherosclerosis.. 83. 2024
Variation in Health Status With Invasive vs Conservative Management of Chronic Coronary Disease.. 83. 2024
Effect of Reconstituted Human Apolipoprotein A-I on Recurrent Ischemic Events in Survivors of Acute MI.. 83. 2024
Incidence, Predictors, and Impact of Hospital Readmission After Revascularization for Left Main Coronary Disease.. 83. 2024
Intraoperative Anemia Mediates Sex Disparity in Operative Mortality After Coronary Artery Bypass Grafting.. 83. 2024
Contemporary Management and Outcomes of Patients With High-Risk Pulmonary Embolism.. 83. 2024
Reporting Extended Follow-Up in Cardiovascular Clinical Trials.. 82. 2023
Sleep-Related Hypoxia, Right Ventricular Dysfunction, and Survival in Patients With Group 1 Pulmonary Arterial Hypertension.. 82. 2023
Outcomes According to Coronary Revascularization Modality in the ISCHEMIA Trial.. 83. 2023
Psychosocial Factors of Women Presenting With Myocardial Infarction With or Without Obstructive Coronary Arteries.. 82. 2023
Risk of Type B Dissection in Marfan Syndrome: The Cornell Aortic Aneurysm Registry. 2023
Predictors of 5-Year Mortality in Patients Managed With a Magnetically Levitated Left Ventricular Assist Device.. 82. 2023
Impact of Malnutrition in Patients With Heart Failure and Secondary Mitral Regurgitation: The COAPT Trial.. 82. 2023
Reconsidering the Direction of Coronary Revascularization Trials.. 81. 2023
Low Utilization of Lead Extraction Among Patients With Infective Endocarditis and Implanted Cardiac Electronic Devices.. 81. 2023
Integrating Psychosocial Care in the Management of Patients With Vascular Disease.. 81. 2023
Prevalence and Complications of Aberrant Subclavian Artery in Patients With Heritable and Nonheritable Arteriopathies.. 81. 2023
Cardiac Damage and Quality of Life After Aortic Valve Replacement in the PARTNER Trials.. 81. 2023
Vein Graft Use and Long-Term Survival Following Coronary Bypass Grafting.. 81. 2023
Hospitalizations and Mortality in Patients With Secondary Mitral Regurgitation and Heart Failure: The COAPT Trial.. 80. 2022
Biomarker-Based Prediction of Recurrent Ischemic Events in Patients With Acute Coronary Syndromes.. 80. 2022
Impediments to Heart Transplantation in Adults With MELAS^{MT-TL1:m.3243A>G} Cardiomyopathy.. 80. 2022
Clinical Characteristics and Transplant-Free Survival Across the Spectrum of Pulmonary Vascular Disease.. 80. 2022
Safety of Provocative Testing With Intracoronary Acetylcholine and Implications for Standard Protocols.. 79. 2022
Cardiovascular Outcomes in Aortopathy: GenTAC Registry of Genetically Triggered Aortic Aneurysms and Related Conditions.. 79. 2022
Worldwide Disparities in Recovery of Cardiac Testing 1 Year Into COVID-19.. 79. 2022
Evolution and Prognostic Impact of Cardiac Damage After Aortic Valve Replacement.. 80. 2022
Outcomes Associated With Peripheral Artery Disease in Myocardial Infarction With Cardiogenic Shock.. 79. 2022
Recovery With Temporary Mechanical Circulatory Support While Waitlisted for Heart Transplantation.. 79. 2022
Life Expectancy After Surgical Aortic Valve Replacement.. 78. 2021
Risk-Benefit of 1-Year DAPT After DES Implantation in Patients Stratified by Bleeding and Ischemic Risk.. 78. 2021
Adverse Cardiovascular and Pulmonary Events Associated With Chimeric Antigen Receptor T-Cell Therapy.. 78. 2021
Pregnancy-Related Aortic Complications in Women With Marfan Syndrome.. 78. 2021
Supplemental Association of Clonal Hematopoiesis With Incident Heart Failure.. 78. 2021
Effectiveness of Blood Lipid Management in Patients With Peripheral Artery Disease.. 77. 2021
Global Prevalence and Impact of Hostility, Discrimination, and Harassment in the Cardiology Workplace.. 77. 2021
Permanent Pacemaker Implantation Following Valve-in-Valve Transcatheter Aortic Valve Replacement: VIVID Registry.. 77. 2021
Mitral Surgery After Transcatheter Edge-to-Edge Repair: Society of Thoracic Surgeons Database Analysis.. 78. 2021
COVID-19 in Adults With Congenital Heart Disease.. 77. 2021
Myocardial T1 and T2 Mapping by Magnetic Resonance in Patients With Immune Checkpoint Inhibitor-Associated Myocarditis.. 77. 2021
International Impact of COVID-19 on the Diagnosis of Heart Disease.. 77. 2021
Association of Age With 10-Year Outcomes After Coronary Surgery in the Arterial Revascularization Trial.. 77. 2021
Diastolic Function and Clinical Outcomes After Transcatheter Aortic Valve Replacement: PARTNER 2 SAPIEN 3 Registry.. 76. 2020
Reliability of Office, Home, and Ambulatory Blood Pressure Measurements and Correlation With Left Ventricular Mass.. 76. 2020
Pulmonary Hypertension in Transcatheter Mitral Valve Repair for Secondary Mitral Regurgitation: The COAPT Trial.. 76. 2020
Characterization of Myocardial Injury in Patients With COVID-19.. 76. 2020
Prognostic Utility of Right Ventricular Remodeling Over Conventional Risk Stratification in Patients With COVID-19.. 76. 2020
Implications of Alternative Definitions of Peri-Procedural Myocardial Infarction After Coronary Revascularization.. 76. 2020
Impact of Tricuspid Regurgitation on Clinical Outcomes: The COAPT Trial.. 76. 2020
Long-Term Survival After Surgical or Percutaneous Revascularization in Patients With Diabetes and Multivessel Coronary Disease.. 76. 2020
Survival and Right Ventricular Function After Surgical Management of Acute Pulmonary Embolism.. 76. 2020
Post-Discharge Bleeding and Mortality Following Acute Coronary Syndromes With or Without PCI.. 76. 2020
Subclinical Leaflet Thrombosis in Transcatheter and Surgical Bioprosthetic Valves: PARTNER 3 Cardiac Computed Tomography Substudy.. 75. 2020
The Impact of COVID-19 on Cardiovascular Training Programs: Challenges, Responsibilities, and Opportunities.. 76. 2020
Survival of Patients With Angina Pectoris Undergoing Percutaneous Coronary Intervention With Intracoronary Pressure Wire Guidance.. 75. 2020
The Consequences of the COVID-19 Pandemic on Non-COVID-19 Clinical Trials.. 76. 2020
Cost-Effectiveness of Alirocumab in Patients With Acute Coronary Syndromes: The ODYSSEY OUTCOMES Trial.. 75. 2020
Effect of Smoking on Outcomes of Primary PCI in Patients With STEMI.. 75. 2020
Long-Term Outcomes in Women and Men Following Percutaneous Coronary Intervention.. 75. 2020
The NCDR Left Atrial Appendage Occlusion Registry.. 75. 2020
Global Longitudinal Strain and Cardiac Events in Patients With Immune Checkpoint Inhibitor-Related Myocarditis.. 75. 2020
Effect of Alirocumab on Lipoprotein(a) and Cardiovascular Risk After Acute Coronary Syndrome.. 75. 2020
Risk of Mortality Following Catheter Ablation of Atrial Fibrillation.. 74. 2019
2019 ACC Health Policy Statement on Cardiologist Compensation and Opportunity Equity.. 74. 2019
Multiple Versus Single Arterial Coronary Bypass Graft Surgery for Multivessel Disease.. 74. 2019
Effects of Alirocumab on Cardiovascular Events After Coronary Bypass Surgery.. 74. 2019
Off-Pump Versus On-Pump Bypass Surgery for Left Main Coronary Artery Disease.. 74. 2019
Burnout and Career Satisfaction Among U.S. Cardiologists.. 73. 2019
Effect of Calcium-Channel Blocker Therapy on Radial Artery Grafts After Coronary Bypass Surgery.. 73. 2019
Alirocumab in Patients With Polyvascular Disease and Recent Acute Coronary Syndrome: ODYSSEY OUTCOMES Trial.. 74. 2019
Academic Advancement in the Current Era: Integrating and Empowering Clinician Educators.. 73. 2019
Cardiac Resynchronization Therapy in Patients With Heart Failure and Narrow QRS Complexes.. 71. 2019
Differences in Risk of Sudden Cardiac Death Between Blacks and Whites.. 72. 2018
Alirocumab Reduces Total Nonfatal Cardiovascular and Fatal Events: The ODYSSEY OUTCOMES Trial.. 73. 2018
Prognostic Value of the Residual SYNTAX Score After Functionally Complete Revascularization in ACS.. 72. 2018
Myocardial Fibrosis in Patients With Primary Mitral Regurgitation With and Without Prolapse.. 72. 2018
Left Main Revascularization With PCI or CABG in Patients With Chronic Kidney Disease: EXCEL Trial.. 72. 2018
1-Year Outcomes of Transcatheter Mitral Valve Replacement in Patients With Severe Mitral Annular Calcification.. 71. 2018
Effect of Aspirin Coadministration on the Safety of Celecoxib, Naproxen, or Ibuprofen.. 71. 2018
Myocarditis in Patients Treated With Immune Checkpoint Inhibitors.. 71. 2018
New-Onset Atrial Fibrillation After PCI or CABG for Left Main Disease: The EXCEL Trial.. 71. 2018
Agreement of the Resting Distal to Aortic Coronary Pressure With the Instantaneous Wave-Free Ratio.. 70. 2017
Characterization of the Average Daily Ischemic and Bleeding Risk After Primary PCI for STEMI.. 70. 2017
Transcatheter Mitral Valve Replacement for Degenerated Bioprosthetic Valves and Failed Annuloplasty Rings.. 70. 2017
Angiotensin-Converting Enzyme Inhibition Early After Heart Transplantation.. 69. 2017
Marfan Syndrome and Quality of Life in the GenTAC Registry.. 69. 2017
Estimating Left Ventricular Filling Pressure by Echocardiography.. 69. 2017
Outcomes in Transcatheter Aortic Valve Replacement for Bicuspid Versus Tricuspid Aortic Valve Stenosis.. 69. 2017
Myocardial Recovery in Patients With Systolic Heart Failure and Autoantibodies Against β₁-Adrenergic Receptors.. 69. 2017
The Changing Landscape for Stroke Prevention in AF: Findings From the GLORIA-AF Registry Phase 2.. 69. 2017
SYNTAX Score and Long-Term Outcomes: The BARI-2D Trial.. 69. 2017
Cangrelor With and Without Glycoprotein IIb/IIIa Inhibitors in Patients Undergoing Percutaneous Coronary Intervention.. 69. 2017
Bleeding Events Before Coronary Angiography in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome.. 68. 2016
Prediction of Poor Outcome After Transcatheter Aortic Valve Replacement.. 68. 2016
52 Genetic Loci Influencing Myocardial Mass.. 68. 2016
Genetic Screening of Anderson-Fabry Disease in Probands Referred From Multispecialty Clinics.. 68. 2016
Efficacy and Safety of Dual Antiplatelet Therapy After Complex PCI.. 68. 2016
2016 ACC/ASE/ASNC/HRS/SCAI Health Policy Statement on Integrating the Healthcare Enterprise.. 68. 2016
Underutilization of Coronary Artery Disease Testing Among Patients Hospitalized With New-Onset Heart Failure.. 68. 2016
Predicting Early and Late Mortality After Transcatheter Aortic Valve Replacement.. 68. 2016
Aortic Dissection in Patients With Genetically Mediated Aneurysms: Incidence and Predictors in the GenTAC Registry.. 67. 2016
Validation of BARC Bleeding Criteria in Patients With Acute Coronary Syndromes: The TRACER Trial.. 67. 2016
Intratracheal Gene Delivery of SERCA2a Ameliorates Chronic Post-Capillary Pulmonary Hypertension: A Large Animal Model.. 67. 2016
The Prognostic Value of Residual Coronary Stenoses After Functionally Complete Revascularization.. 67. 2016
Cost-Effectiveness of Transcatheter Aortic Valve Replacement With a Self-Expanding Prosthesis Versus Surgical Aortic Valve Replacement.. 67. 2016
Enhanced Cardiac Regenerative Ability of Stem Cells After Ischemia-Reperfusion Injury: Role of Human CD34+ Cells Deficient in MicroRNA-377.. 66. 2015
CABG Versus PCI: Greater Benefit in Long-Term Outcomes With Multiple Arterial Bypass Grafting.. 66. 2015
Serum Biomarkers of Inflammation, Fibrosis, and Cardiac Function in Facilitating Diagnosis, Prognosis, and Treatment of Anti-SSA/Ro-Associated Cardiac Neonatal Lupus.. 66. 2015
Hospital length of stay and clinical outcomes in older STEMI patients after primary PCI: a report from the National Cardiovascular Data Registry.. 65. 2015
Task Force 3: Pediatric Cardiology Fellowship Training in Cardiac Catheterization.. 66. 2015
Economic analysis of ticagrelor therapy from a U.S. perspective: results from the PLATO study.. 65. 2015
Short- and long-term cause of death in patients treated with primary PCI for STEMI.. 64. 2014
Cor pulmonale parvus in chronic obstructive pulmonary disease and emphysema: the MESA COPD study.. 64. 2014
The relationship of left ventricular trabeculation to ventricular function and structure over a 9.5-year follow-up: the MESA study.. 64. 2014
Assessment of the 12-lead electrocardiogram as a screening test for detection of cardiovascular disease in healthy general populations of young people (12-25 years of age): a scientific statement from the American Heart Association and the American College of Cardiology.. 64. 2014
High-risk plaque detected on coronary CT angiography predicts acute coronary syndromes independent of significant stenosis in acute chest pain: results from the ROMICAT-II trial.. 64. 2014
Early safety and efficacy of percutaneous left atrial appendage suture ligation: results from the U.S. transcatheter LAA ligation consortium.. 64. 2014
SCAI/AATS/ACC/STS operator and institutional requirements for transcatheter valve repair and replacement. Part II. mitral valve.. 64. 2014
Appropriateness of primary prevention implantable cardioverter-defibrillators at the time of generator replacement: are indications still met?. 63. 2014
Results of the destination therapy post-food and drug administration approval study with a continuous flow left ventricular assist device: a prospective study using the INTERMACS registry (Interagency Registry for Mechanically Assisted Circulatory Support).. 63. 2014
Ethanol infusion in the vein of Marshall leads to parasympathetic denervation of the human left atrium: implications for atrial fibrillation.. 63. 2014
Ticagrelor effects on myocardial infarction and the impact of event adjudication in the PLATO (Platelet Inhibition and Patient Outcomes) trial.. 63. 2014
Feasibility and safety of uninterrupted rivaroxaban for periprocedural anticoagulation in patients undergoing radiofrequency ablation for atrial fibrillation: results from a multicenter prospective registry.. 63. 2014
Vorapaxar in acute coronary syndrome patients undergoing coronary artery bypass graft surgery: subgroup analysis from the TRACER trial (Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome).. 63. 2013
Earlier arterial switch operation improves outcomes and reduces costs for neonates with transposition of the great arteries.. 63. 2013
Impact of intraprocedural stent thrombosis during percutaneous coronary intervention: insights from the CHAMPION PHOENIX Trial (Clinical Trial Comparing Cangrelor to Clopidogrel Standard of Care Therapy in Subjects Who Require Percutaneous Coronary Intervention).. 63. 2013
Alternative ankle-brachial index method identifies additional at-risk individuals.. 62. 2013
Effects of bariatric surgery on human small artery function: evidence for reduction in perivascular adipocyte inflammation, and the restoration of normal anticontractile activity despite persistent obesity.. 62. 2013
Nonsystem reasons for delay in door-to-balloon time and associated in-hospital mortality: a report from the National Cardiovascular Data Registry.. 61. 2013
ACCF/HRS/AHA/ASE/HFSA/SCAI/SCCT/SCMR 2013 appropriate use criteria for implantable cardioverter-defibrillators and cardiac resynchronization therapy: a report of the American College of Cardiology Foundation appropriate use criteria task force, Heart Rhythm Society, American Heart Association, American Society of Echocardiography, Heart Failure Society of America, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and Society for Cardiovascular Magnetic Resonance.. 61. 2013
Appropriate use of cardiovascular technology: 2013 ACCF appropriate use criteria methodology update: a report of the American College of Cardiology Foundation appropriate use criteria task force.. 61. 2013
2013 ACCF/AHA key data elements and definitions for measuring the clinical management and outcomes of patients with acute coronary syndromes and coronary artery disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on clinical data standards (writing committee to develop acute coronary syndromes and coronary artery disease clinical data standards).. 61. 2013
The prevalence and outcomes of transradial percutaneous coronary intervention for ST-segment elevation myocardial infarction: analysis from the National Cardiovascular Data Registry (2007 to 2011).. 61. 2012
Incidence of heart failure or cardiomyopathy after adjuvant trastuzumab therapy for breast cancer.. 60. 2012
Quantitative expression of the mutated lamin A/C gene in patients with cardiolaminopathy.. 60. 2012
Vascular complications after transcatheter aortic valve replacement: insights from the PARTNER (Placement of AoRTic TraNscathetER Valve) trial.. 60. 2012
Assessment of myocardial scarring improves risk stratification in patients evaluated for cardiac defibrillator implantation.. 60. 2012
Temporal trends in and factors associated with bleeding complications among patients undergoing percutaneous coronary intervention: a report from the National Cardiovascular Data CathPCI Registry.. 59. 2012
Impact of QRS duration and morphology on the risk of sudden cardiac death in asymptomatic patients with aortic stenosis: the SEAS (Simvastatin and Ezetimibe in Aortic Stenosis) Study.. 59. 2012
Alcohol septal ablation for the treatment of hypertrophic obstructive cardiomyopathy. A multicenter North American registry.. 58. 2011
Factors associated with subsequent arch reintervention after initial balloon aortoplasty in patients with Norwood procedure and arch obstruction.. 58. 2011
Prognostic impact of staged versus "one-time" multivessel percutaneous intervention in acute myocardial infarction: analysis from the HORIZONS-AMI (harmonizing outcomes with revascularization and stents in acute myocardial infarction) trial.. 58. 2011
Aortic expansion rate in patients with dilated post-stenotic ascending aorta submitted only to aortic valve replacement long-term follow-up.. 58. 2011
Mortality risk in symptomatic patients with nonobstructive coronary artery disease: a prospective 2-center study of 2,583 patients undergoing 64-detector row coronary computed tomographic angiography.. 58. 2011
Imaging of the aortic valve using fluorodeoxyglucose positron emission tomography increased valvular fluorodeoxyglucose uptake in aortic stenosis.. 57. 2011
Results of the post-U.S. Food and Drug Administration-approval study with a continuous flow left ventricular assist device as a bridge to heart transplantation: a prospective study using the INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support).. 57. 2011
The incidence of bradyarrhythmias and clinical bradyarrhythmic events in patients with acute coronary syndromes treated with ticagrelor or clopidogrel in the PLATO (Platelet Inhibition and Patient Outcomes) trial: results of the continuous electrocardiographic assessment substudy.. 57. 2011
Positron emission tomography measurement of periodontal 18F-fluorodeoxyglucose uptake is associated with histologically determined carotid plaque inflammation.. 57. 2011
β-trace protein and cystatin C as predictors of long-term outcomes in patients with acute heart failure.. 57. 2011
Cardiac effects of antiretroviral therapy in HIV-negative infants born to HIV-positive mothers: NHLBI CHAART-1 (National Heart, Lung, and Blood Institute Cardiovascular Status of HAART Therapy in HIV-Exposed Infants and Children cohort study).. 57. 2011
Ticagrelor versus clopidogrel in patients with acute coronary syndromes undergoing coronary artery bypass surgery: results from the PLATO (Platelet Inhibition and Patient Outcomes) trial.. 57. 2010
Iodofiltic acid I 123 (BMIPP) fatty acid imaging improves initial diagnosis in emergency department patients with suspected acute coronary syndromes: a multicenter trial.. 56. 2010
Acquired von Willebrand syndrome after continuous-flow mechanical device support contributes to a high prevalence of bleeding during long-term support and at the time of transplantation.. 56. 2010
Cardiovascular events during differing hypertension therapies in patients with diabetes.. 56. 2010
Common functional genetic variants in catecholamine storage vesicle protein promoter motifs interact to trigger systemic hypertension.. 55. 2010
Determinants of coronary calcium conversion among patients with a normal coronary calcium scan: what is the "warranty period" for remaining normal?. 55. 2010
A multicenter assessment of the use of single-photon emission computed tomography myocardial perfusion imaging with appropriateness criteria.. 55. 2010
Stent gap by 64-detector computed tomographic angiography relationship to in-stent restenosis, fracture, and overlap failure.. 54. 2009
Normal stress-only versus standard stress/rest myocardial perfusion imaging: similar patient mortality with reduced radiation exposure.. 55. 2009
The coronary artery calcium score and stress myocardial perfusion imaging provide independent and complementary prediction of cardiac risk.. 54. 2009
Delayed untwisting: the mechanistic link between dynamic obstruction and exercise tolerance in patients with hypertrophic obstructive cardiomyopathy.. 54. 2009
Neuropeptide Y(1) Receptor NPY1R discovery of naturally occurring human genetic variants governing gene expression in cella as well as pleiotropic effects on autonomic activity and blood pressure in vivo.. 54. 2009
Extended mechanical circulatory support with a continuous-flow rotary left ventricular assist device.. 54. 2009
Clinical effectiveness of coronary stents in elderly persons: results from 262,700 Medicare patients in the American College of Cardiology-National Cardiovascular Data Registry.. 53. 2009
Coronary computed tomography angiography for early triage of patients with acute chest pain: the ROMICAT (Rule Out Myocardial Infarction using Computer Assisted Tomography) trial.. 53. 2009
Real-time 3-dimensional transesophageal echocardiography in the evaluation of post-operative mitral annuloplasty ring and prosthetic valve dehiscence.. 53. 2009
Impact of contrast echocardiography on evaluation of ventricular function and clinical management in a large prospective cohort.. 53. 2009
Effect of physician volume on the relationship between hospital volume and mortality during primary angioplasty.. 53. 2009
The ABCD (Alternans Before Cardioverter Defibrillator) Trial: strategies using T-wave alternans to improve efficiency of sudden cardiac death prevention.. 53. 2009
Naturally occurring human genetic variation in the 3'-untranslated region of the secretory protein chromogranin A is associated with autonomic blood pressure regulation and hypertension in a sex-dependent fashion.. 52. 2008
Localization of atrial fibrillation triggers in patients undergoing pulmonary vein isolation: importance of the carina region.. 52. 2008
Detection of left ventricular thrombus by delayed-enhancement cardiovascular magnetic resonance prevalence and markers in patients with systolic dysfunction.. 52. 2008
Survival and clinical course at Fontan after stage one palliation with either a modified Blalock-Taussig shunt or a right ventricle to pulmonary artery conduit.. 52. 2008
Cockcroft-Gault versus modification of diet in renal disease: importance of glomerular filtration rate formula for classification of chronic kidney disease in patients with non-ST-segment elevation acute coronary syndromes.. 51. 2008
Inhibition of platelet aggregation by AZD6140, a reversible oral P2Y12 receptor antagonist, compared with clopidogrel in patients with acute coronary syndromes.. 50. 2007
Safety, tolerability, and initial efficacy of AZD6140, the first reversible oral adenosine diphosphate receptor antagonist, compared with clopidogrel, in patients with non-ST-segment elevation acute coronary syndrome: primary results of the DISPERSE-2 trial.. 50. 2007
Supine bicycle echocardiography improved diagnostic accuracy and physiologic assessment of coronary artery disease with the incorporation of intermediate stages of exercise.. 50. 2007
Prognostic value of multidetector coronary computed tomographic angiography for prediction of all-cause mortality.. 50. 2007
Outcome of surgical myectomy after unsuccessful alcohol septal ablation for the treatment of patients with hypertrophic obstructive cardiomyopathy.. 50. 2007
Predictive value of microvolt T-wave alternans in patients with left ventricular dysfunction.. 50. 2007
Results of the U.S. multicenter pivotal study of the HELEX septal occluder for percutaneous closure of secundum atrial septal defects.. 49. 2007
Clinical and electrophysiological spectrum of idiopathic ventricular outflow tract arrhythmias.. 49. 2007
Adenosine-insensitive focal atrial tachycardia: evidence for de novo micro-re-entry in the human atrium.. 49. 2007
Dimethylarginine dimethylaminohydrolase promotes endothelial repair after vascular injury.. 49. 2007
Aortic root translocation plus arterial switch for transposition of the great arteries with left ventricular outflow tract obstruction: intermediate-term results.. 49. 2007
A multinational study to establish the value of early adenosine technetium-99m sestamibi myocardial perfusion imaging in identifying a low-risk group for early hospital discharge after acute myocardial infarction.. 48. 2006
An initial strategy of intensive medical therapy is comparable to that of coronary revascularization for suppression of scintigraphic ischemia in high-risk but stable survivors of acute myocardial infarction.. 48. 2006
Endothelial progenitor cells participate in nicotine-mediated angiogenesis.. 48. 2006
Effects of high-dose atorvastatin on cerebrovascular events in patients with stable coronary disease in the TNT (treating to new targets) study.. 48. 2006
The influence of peripheral arterial disease on outcomes: a pooled analysis of mortality in eight large randomized percutaneous coronary intervention trials.. 48. 2006
Effects of selective matrix metalloproteinase inhibitor (PG-116800) to prevent ventricular remodeling after myocardial infarction: results of the PREMIER (Prevention of Myocardial Infarction Early Remodeling) trial.. 48. 2006
Impact of obesity on cardiac geometry and function in a population of adolescents: the Strong Heart Study.. 47. 2006
Effects of time, dose, and inversion time for acute myocardial infarct size measurements based on magnetic resonance imaging-delayed contrast enhancement.. 47. 2006
Improved detection of coronary artery disease by stress perfusion cardiovascular magnetic resonance with the use of delayed enhancement infarction imaging.. 47. 2006
A comparison of the clinical impact of bleeding measured by two different classifications among patients with acute coronary syndromes.. 47. 2006
Frequency and clinical implications of discordant creatine kinase-MB and troponin measurements in acute coronary syndromes.. 47. 2006
Initial clinical experience with regadenoson, a novel selective A2A agonist for pharmacologic stress single-photon emission computed tomography myocardial perfusion imaging.. 46. 2005
The effect of losartan versus atenolol on cardiovascular morbidity and mortality in patients with hypertension taking aspirin: the Losartan Intervention for Endpoint Reduction in hypertension (LIFE) study.. 46. 2005
Use of bivalirudin during percutaneous coronary intervention in patients with diabetes mellitus: an analysis from the randomized evaluation in percutaneous coronary intervention linking angiomax to reduced clinical events (REPLACE)-2 trial.. 45. 2005
Effects of left ventricular assist device therapy on ventricular arrhythmias.. 45. 2005
A common PCSK9 haplotype, encompassing the E670G coding single nucleotide polymorphism, is a novel genetic marker for plasma low-density lipoprotein cholesterol levels and severity of coronary atherosclerosis.. 45. 2005
Incremental predictive power of B-type natriuretic peptide and tissue Doppler echocardiography in the prognosis of patients with congestive heart failure.. 45. 2005
Outcomes with the polymer-based paclitaxel-eluting TAXUS stent in patients with diabetes mellitus: the TAXUS-IV trial.. 45. 2005
Polymer-based paclitaxel-eluting stents reduce in-stent neointimal tissue proliferation: a serial volumetric intravascular ultrasound analysis from the TAXUS-IV trial.. 45. 2005
Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: the Losartan Intervention For End Point Reduction in Hypertension (LIFE) study.. 45. 2005
Cardiovascular morbidity and mortality in hypertensive patients with a history of atrial fibrillation: The Losartan Intervention For End Point Reduction in Hypertension (LIFE) study.. 45. 2005
Left ventricular assist device support normalizes left and right ventricular beta-adrenergic pathway properties.. 45. 2005
Intravascular ultrasound-guided treatment for angiographically indeterminate left main coronary artery disease: a long-term follow-up study.. 45. 2005
President's page: The future is now: ACC goes to Washington.. 45. 2005
Effects of a novel immune modulation therapy in patients with advanced chronic heart failure: results of a randomized, controlled, phase II trial.. 44. 2004
Myocardial ischemia and infarction.. 44. 2004
Association of a pulsatile blood flow pattern on coronary arteriography and short-term clinical outcomes in acute myocardial infarction.. 43. 2004
Aspirin dose and six-month outcome after an acute coronary syndrome.. 43. 2004
Cardiovascular risk reduction in hypertensive black patients with left ventricular hypertrophy: the LIFE study.. 43. 2004
Molecular normalization of dystrophin in the failing left and right ventricle of patients treated with either pulsatile or continuous flow-type ventricular assist devices.. 43. 2004
Improved speed and stability of ST-segment recovery with reduced-dose tenecteplase and eptifibatide compared with full-dose tenecteplase for acute ST-segment elevation myocardial infarction.. 43. 2004
Phospholipid abnormalities in children with Barth syndrome.. 42. 2003
A randomized, double-blind, placebo-controlled trial of Ad5FGF-4 gene therapy and its effect on myocardial perfusion in patients with stable angina.. 42. 2003
Correlates of one-year survival inpatients with cardiogenic shock complicating acute myocardial infarction: angiographic findings from the SHOCK trial.. 42. 2003
Percutaneous coronary intervention for cardiogenic shock in the SHOCK trial.. 42. 2003
Age does not limit quality of life improvement in cardiac valve surgery.. 42. 2003
Competing autonomic mechanisms precede the onset of postoperative atrial fibrillation.. 42. 2003
Complete heart block: determinants and clinical impact in patients with hypertrophic obstructive cardiomyopathy undergoing nonsurgical septal reduction therapy.. 42. 2003
Hemodynamic and clinical effects of tezosentan, an intravenous dual endothelin receptor antagonist, in patients hospitalized for acute decompensated heart failure.. 42. 2003
Association of albuminuria with systolic and diastolic left ventricular dysfunction in type 2 diabetes: the Strong Heart Study.. 41. 2003
Poverty, process of care, and outcome in acute coronary syndromes.. 41. 2003
Combination reperfusion therapy with eptifibatide and reduced-dose tenecteplase for ST-elevation myocardial infarction: results of the integrilin and tenecteplase in acute myocardial infarction (INTEGRITI) Phase II Angiographic Trial.. 41. 2003
Nicotine promotes arteriogenesis.. 41. 2003
Relationship between heparin anticoagulation and clinical outcomes in coronary stent intervention: observations from the ESPRIT trial.. 41. 2003
Troponin T and quantitative ST-segment depression offer complementary prognostic information in the risk stratification of acute coronary syndrome patients.. 41. 2003
Release of matrix metalloproteinases following alcohol septal ablation in hypertrophic obstructive cardiomyopathy.. 40. 2002
Quantitative assessment of electrocardiographic strain predicts increased left ventricular mass: the Strong Heart Study.. 40. 2002
Homocysteine impairs coronary microvascular dilator function in humans.. 40. 2002
Percutaneous coronary interventions in octogenarians in the American College of Cardiology-National Cardiovascular Data Registry: development of a nomogram predictive of in-hospital mortality.. 40. 2002
Do atrial tachyarrhythmias beget ventricular tachyarrhythmias in defibrillator recipients?. 40. 2002
Early angioplasty in acute coronary syndromes without persistent ST-segment elevation improves outcome but increases the need for six-month repeat revascularization: an analysis of the PURSUIT Trial. Platelet glycoprotein IIB/IIIA in Unstable angina: Receptor Suppression Using Integrilin Therapy.. 39. 2002
Lesional tachycardias related to mitral valve surgery.. 39. 2002
Active interstitial remodeling: an important process in the hibernating human myocardium.. 39. 2002
American College of Cardiology key data elements and definitions for measuring the clinical management and outcomes of patients with acute coronary syndromes. A report of the American College of Cardiology Task Force on Clinical Data Standards (Acute Coronary Syndromes Writing Committee).. 38. 2001
Absence of gender differences in clinical outcomes in patients with cardiogenic shock complicating acute myocardial infarction. A report from the SHOCK Trial Registry.. 38. 2001
Vascular complications after percutaneous coronary interventions following hemostasis with manual compression versus arteriotomy closure devices.. 38. 2001
Relationship of the electrocardiographic strain pattern to left ventricular structure and function in hypertensive patients: the LIFE study. Losartan Intervention For End point.. 38. 2001
Initiation of hormone replacement therapy after acute myocardial infarction is associated with more cardiac events during follow-up.. 38. 2001
Mild-to-moderate hypertriglyceridemia in young men is associated with endothelial dysfunction and increased plasma concentrations of asymmetric dimethylarginine.. 38. 2001
Physical training in patients with chronic heart failure enhances the expression of genes encoding antioxidative enzymes.. 38. 2001
Prognostic value of ST segment depression in acute coronary syndromes: insights from PARAGON-A applied to GUSTO-IIb. PARAGON-A and GUSTO IIb Investigators. Platelet IIb/IIIa Antagonism for the Reduction of Acute Global Organization Network.. 38. 2001
The impact of diabetes on left ventricular filling pattern in normotensive and hypertensive adults: the Strong Heart Study.. 37. 2001
Therapeutic value of eptifibatide at community hospitals transferring patients to tertiary referral centers early after admission for acute coronary syndromes. PURSUIT Investigators.. 37. 2001
An endogenous inhibitor of nitric oxide synthase regulates endothelial adhesiveness for monocytes.. 36. 2000
Obstacle-induced transition from ventricular fibrillation to tachycardia in isolated swine right ventricles: insights into the transition dynamics and implications for the critical mass.. 36. 2000
Apolipoprotein E genotypes and response of plasma lipids and progression-regression of coronary atherosclerosis to lipid-lowering drug therapy.. 36. 2000
Angiographic findings and clinical correlates in patients with cardiogenic shock complicating acute myocardial infarction: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK?. 36. 2000
Relation of tissue Doppler derived myocardial velocities to myocardial structure and beta-adrenergic receptor density in humans.. 36. 2000
Prevalence and correlates of aortic regurgitation in American Indians: the Strong Heart Study.. 36. 2000
Occurrence and clinical significance of pseudothrombocytopenia during abciximab therapy.. 36. 2000
Echocardiographic predictors of clinical outcome in patients with left ventricular dysfunction enrolled in the SOLVD registry and trials: significance of left ventricular hypertrophy. Studies of Left Ventricular Dysfunction.. 35. 2000
End-diastolic wall thickness as a predictor of recovery of function in myocardial hibernation: relation to rest-redistribution T1-201 tomography and dobutamine stress echocardiography.. 35. 2000
The future of cardiology: utilization and costs of care.. 35. 2000
The future of cardiology: utilization and costs of care.. 35. 2000
Interactions between angiotensin-I converting enzyme insertion/deletion polymorphism and response of plasma lipids and coronary atherosclerosis to treatment with fluvastatin: the lipoprotein and coronary atherosclerosis study.. 35. 2000
Comparison of a novel rectilinear biphasic waveform with a damped sine wave monophasic waveform for transthoracic ventricular defibrillation. ZOLL Investigators.. 34. 1999
Reliability of echocardiographic assessment of left ventricular structure and function: the PRESERVE study. Prospective Randomized Study Evaluating Regression of Ventricular Enlargement.. 34. 1999
Changes in left ventricular filling and left atrial function six months after nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy.. 34. 1999
Gene transfer of nitric oxide synthase: effects on endothelial biology.. 34. 1999
Long-term outcome of patients with unexplained syncope treated with an electrophysiologic-guided approach in the implantable cardioverter-defibrillator era.. 34. 1999
Blood flow-metabolism imaging with positron emission tomography in patients with diabetes mellitus for the assessment of reversible left ventricular contractile dysfunction.. 33. 1999
Clinical outcomes after detection of elevated cardiac enzymes in patients undergoing percutaneous intervention. IMPACT-II Investigators. Integrilin (eptifibatide) to Minimize Platelet Aggregation and Coronary Thrombosis-II.. 33. 1999
Association of chronotropic incompetence with echocardiographic ischemia and prognosis.. 32. 1998
Differentiating thrombus from pannus formation in obstructed mechanical prosthetic valves: an evaluation of clinical, transthoracic and transesophageal echocardiographic parameters.. 32. 1998
Prognostic value of congestive heart failure history in patients undergoing percutaneous coronary interventions.. 32. 1998
Occurrence and clinical significance of thrombocytopenia in a population undergoing high-risk percutaneous coronary revascularization. Evaluation of c7E3 for the Prevention of Ischemic Complications (EPIC) Study Group.. 32. 1998
Role of myocardial contrast echocardiography during nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy.. 32. 1998
Use of balloon-expandable stents for coarctation of the aorta: initial results and intermediate-term follow-up.. 30. 1997
Doppler tissue imaging: a noninvasive technique for evaluation of left ventricular relaxation and estimation of filling pressures.. 30. 1997
Pathologic correlates of aortic plaques, thrombi and mobile "aortic debris" imaged in vivo with transesophageal echocardiography.. 30. 1997
Evidence for prevention of death and myocardial infarction with platelet membrane glycoprotein IIb/IIIa receptor blockade by abciximab (c7E3 Fab) among patients with unstable angina undergoing percutaneous coronary revascularization. EPIC Investigators. Evaluation of 7E3 in Preventing Ischemic Complications.. 30. 1997
Nicotine patch therapy in smoking cessation reduces the extent of exercise-induced myocardial ischemia.. 30. 1997
Outcome and profile of women and men presenting with acute coronary syndromes: a report from TIMI IIIB. TIMI Investigators. Thrombolysis in Myocardial Infarction.. 30. 1997
Association of angiotensin I-converting enzyme gene polymorphism with myocardial ischemia and patency of infarct-related artery in patients with acute myocardial infarction.. 29. 1997
Relation between clinical, angiographic and ischemic findings at baseline and ischemia-related adverse outcomes at 1 year in the Asymptomatic Cardiac Ischemia Pilot study. ACIP Study Group.. 29. 1997
Adenosine thallium-201 tomography in evaluation of graft patency late after coronary artery bypass graft surgery.. 29. 1997
Relation of hemodynamic volume load to arterial and cardiac size.. 29. 1997
Relation between ambulatory electrocardiographic monitoring and myocardial perfusion imaging to detect coronary artery disease and myocardial ischemia: an ACIP ancillary study. The Asymptomatic Cardiac Ischemia Pilot (ACIP) Investigators.. 29. 1997
Dietary L-arginine supplementation normalizes platelet aggregation in hypercholesterolemic humans.. 29. 1997
Acute results of balloon angioplasty of native coarctation versus recurrent aortic obstruction are equivalent. Valvuloplasty and Angioplasty of Congenital Anomalies (VACA) Registry Investigators.. 28. 1996
Cardiovascular effects of exercise: role of endothelial shear stress.. 28. 1996
Effect of managed care on cardiovascular specialists: involvement, attitudes and practice adaptations.. 28. 1996
Arginine restores nitric oxide activity and inhibits monocyte accumulation after vascular injury in hypercholesterolemic rabbits.. 28. 1996
QT interval-heart rate relation during exercise in normal men and women: definition by linear regression analysis.. 28. 1996
Detection of left anterior descending coronary artery stenosis in patients with left bundle branch block: exercise, adenosine or dobutamine imaging?. 28. 1996
Prognostic value of heart rate adjustment of exercise-induced ST segment depression in the multiple risk factor intervention trial.. 27. 1996
Posterior fast atrioventricular node pathways: implications for radiofrequency catheter ablation of atrioventricular node reentrant tachycardia.. 27. 1996
Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the Studies of Left Ventricular Dysfunction (SOLVD).. 27. 1996
Family history of severe cardiovascular disease in Marfan syndrome is associated with increased aortic diameter and decreased survival.. 26. 1995
Asymptomatic Cardiac Ischemia Pilot (ACIP) study: effects of coronary angioplasty and coronary artery bypass graft surgery on recurrent angina and ischemia. The ACIP investigators.. 26. 1995
Asymptomatic Cardiac Ischemia Pilot (ACIP) study: outcome at 1 year for patients with asymptomatic cardiac ischemia randomized to medical therapy or revascularization. The ACIP Investigators.. 26. 1995
Immediate results and late outcomes after stent implantation in saphenous vein graft lesions: the multicenter U.S. Palmaz-Schatz stent experience. The Palmaz-Schatz Stent Study Group.. 26. 1995
Small stent size and intimal hyperplasia contribute to restenosis: a volumetric intravascular ultrasound analysis.. 26. 1995
Myocardial contrast echocardiography: relation of collateral perfusion to extent of injury and severity of contractile dysfunction in a canine model of coronary thrombosis and reperfusion.. 26. 1995
Characteristics and consequences of myocardial infarction after percutaneous coronary intervention: insights from the Coronary Angioplasty Versus Excisional Atherectomy Trial (CAVEAT).. 25. 1995
Simultaneous assessment of myocardial perfusion and left ventricular function during transient coronary occlusion.. 25. 1995
Role of adenosine thallium-201 tomography for defining long-term risk in patients after acute myocardial infarction.. 25. 1995
Effect of growth on variability of left ventricular mass: assessment of allometric signals in adults and children and their capacity to predict cardiovascular risk.. 25. 1995
Risk stratification for arrhythmic events in patients with nonischemic dilated cardiomyopathy and nonsustained ventricular tachycardia: role of programmed ventricular stimulation and the signal-averaged electrocardiogram.. 24. 1994
Transdermal nitroglycerin patch therapy reduces the extent of exercise-induced myocardial ischemia: results of a double-blind, placebo-controlled trial using quantitative thallium-201 tomography.. 24. 1994
Relation of neurohumoral activation to clinical variables and degree of ventricular dysfunction: a report from the Registry of Studies of Left Ventricular Dysfunction. SOLVD Investigators.. 23. 1994
Clinical importance of thrombocytopenia occurring in the hospital phase after administration of thrombolytic therapy for acute myocardial infarction. The Thrombolysis and Angioplasty in Myocardial Infarction Study Group.. 23. 1994
Dietary arginine prevents atherogenesis in the coronary artery of the hypercholesterolemic rabbit.. 23. 1994
Relation of arterial pressure waveform to left ventricular and carotid anatomy in normotensive subjects.. 22. 1993
Comparative neurohormonal responses in patients with preserved and impaired left ventricular ejection fraction: results of the Studies of Left Ventricular Dysfunction (SOLVD) Registry. The SOLVD Investigators.. 22. 1993
Measurement variables for optimal performance of the ST integral.. 22. 1993
Dobutamine thallium-201 tomography for evaluating patients with suspected coronary artery disease unable to undergo exercise or vasodilator pharmacologic stress testing.. 21. 1993
Effects of acute, transient coronary occlusion on global and regional right ventricular function in humans.. 20. 1992
Electrocardiographic detection of left ventricular hypertrophy by the simple QRS voltage-duration product.. 20. 1992
Equivalence between adenosine and exercise thallium-201 myocardial tomography: a multicenter, prospective, crossover trial.. 20. 1992
Transesophageal echocardiography. American College of Cardiology position statement.. 20. 1992
Estimation of left ventricular end-diastolic pressure from Doppler transmitral flow velocity in cardiac patients independent of systolic performance.. 20. 1992
Effects of diltiazem on recurrent myocardial infarction in patients with non-Q wave myocardial infarction.. 19. 1992
Hyperlipidemia after heart transplantation: report of a 6-year experience, with treatment recommendations.. 19. 1992
Relation of perfusion defects observed with myocardial contrast echocardiography to the severity of coronary stenosis: correlation with thallium-201 single-photon emission tomography.. 19. 1992
Adenosine-induced atrioventricular block: a rapid and reliable method to assess surgical and radiofrequency catheter ablation of accessory atrioventricular pathways.. 19. 1992
Association of aortic dilation with regurgitant, stenotic and functionally normal bicuspid aortic valves.. 19. 1992
Quantification of left ventricular performance during transient coronary occlusion at various anatomic sites in humans: a study using tantalum-178 and a multiwire gamma camera.. 19. 1992
Heart rate adjustment of the time-voltage ST segment integral: identification of coronary disease and relation to standard and heart rate-adjusted ST segment depression criteria.. 18. 1991
Lipoprotein(a) and apolipoprotein changes after cardiac transplantation.. 18. 1991
Quantitative thallium-201 single-photon emission computed tomography during maximal pharmacologic coronary vasodilation with adenosine for assessing coronary artery disease.. 18. 1991
Tolerance and safety of pharmacologic coronary vasodilation with adenosine in association with thallium-201 scintigraphy in patients with suspected coronary artery disease.. 18. 1991
Criteria for the accurate interpretation of changes in left ventricular ejection fraction and cardiac volumes as assessed by rest and exercise gated radionuclide angiography.. 18. 1991
Events in the Cardiac Arrhythmia Suppression Trial (CAST): mortality in patients surviving open label titration but not randomized to double-blind therapy.. 18. 1991
The automatic implantable cardioverter-defibrillator: effect of patch polarity on defibrillation threshold.. 17. 1991
The variable extent of jeopardized myocardium in patients with single vessel coronary artery disease: quantification by thallium-201 single photon emission computed tomography.. 17. 1991
Safety and efficacy of a new transpulmonary ultrasound contrast agent: initial multicenter clinical results.. 16. 1990
The signal-averaged electrocardiogram and ventricular arrhythmias after thrombolysis for acute myocardial infarction.. 15. 1990
Day-to-day variability of voltage measurements used in electrocardiographic criteria for left ventricular hypertrophy.. 15. 1990
Quantitative exercise thallium-201 single photon emission computed tomography for the enhanced diagnosis of ischemic heart disease.. 15. 1990
Assessment of regional myocardial perfusion by contrast echocardiography. II. Detection of changes in transmural and subendocardial perfusion during dipyridamole-induced hyperemia in a model of critical coronary stenosis.. 14. 1989
Serial quantitative planar technetium-99m isonitrile imaging in acute myocardial infarction: efficacy for noninvasive assessment of thrombolytic therapy.. 14. 1989
Left ventricular diastolic dysfunction: early diastolic relaxation and late diastolic compliance.. 13. 1989
The St. Jude valve prosthesis: analysis of the clinical results in 815 implants and the need for systemic anticoagulation.. 13. 1989
Quantification of myocardial infarction during coronary occlusion and myocardial salvage after reperfusion using cardiac imaging with technetium-99m hexakis 2-methoxyisobutyl isonitrile.. 12. 1988
Current-based versus energy-based ventricular defibrillation: a prospective study.. 12. 1988
Relation of blood pressure and body build to left ventricular mass in normotensive and hypertensive employed adults.. 12. 1988
Left ventricular mass in children and adolescents.. 12. 1988
Clinical significance of perfusion defects by thallium-201 single photon emission tomography following oral dipyridamole early after coronary angioplasty.. 11. 1988
Quantitative thallium-201 single photon emission computed tomography after oral dipyridamole for assessing the presence, anatomic location and severity of coronary artery disease.. 11. 1988
Surgical treatment of right atrial focal tachycardia in adults.. 11. 1988
Assessment of myocardial perfusion in humans by contrast echocardiography. I. Evaluation of regional coronary reserve by peak contrast intensity.. 11. 1988
Quantitative assessment of left ventricular wall motion by two-dimensional echocardiography: validation during reversible ischemia in the conscious dog.. 11. 1988
End-systolic radius to thickness ratio: an echocardiographic index of regional performance during reversible myocardial ischemia in the conscious dog.. 10. 1987
Relation between amiodarone and desethylamiodarone plasma concentrations and electrophysiologic effects, efficacy and toxicity.. 9. 1987
Gated blood pool scintigraphic monitoring of doxorubicin cardiomyopathy: comparison of camera and computerized probe results in 101 patients.. 8. 1986
Relation between clinical features of the mitral prolapse syndrome and echocardiographically documented mitral valve prolapse.. 8. 1986
Effects of recent and remote infarction on the predictive accuracy of the ST segment/heart rate slope.. 8. 1986
Determination of regurgitant fraction in isolated mitral or aortic regurgitation by pulsed Doppler two-dimensional echocardiography.. 7. 1986
The prevalence and correlates of echocardiographic left ventricular hypertrophy among employed patients with uncomplicated hypertension.. 7. 1986
Early infarct expansion: structural or functional?. 6. 1985
Sustained ventricular tachyarrhythmias within 2 months of acute myocardial infarction: results of medical and surgical therapy in patients resuscitated from the initial episode.. 6. 1985
Electrocardiographic detection of left ventricular hypertrophy: development and prospective validation of improved criteria.. 6. 1985
Diagnostic and therapeutic use of adenosine in patients with supraventricular tachyarrhythmias.. 6. 1985
Plasma epinephrine concentration in healthy men: correlation with systolic pressure and rate-pressure product.. 5. 1985
Standardization of M-mode echocardiographic left ventricular anatomic measurements.. 4. 1984
Comparison of two-dimensional echocardiography with gated radionuclide ventriculography in the evaluation of global and regional left ventricular function in acute myocardial infarction.. 3. 1984
Use of electrocardiographic-thallium exercise testing in clinical practice.. 3. 1984
Duration of ejection in aortic stenosis: effect of stroke volume and pressure gradient.. 3. 1984
Electrocardiographic detection of left ventricular hypertrophy using echocardiographic determination of left ventricular mass as the reference standard. Comparison of standard criteria, computer diagnosis and physician interpretation.. 3. 1984
Reply: Calcium-Channel Blockers in Patients With Radial Artery Grafts: Art Versus Science.. 74. 2019
Reply: Left Atrial Appendage Occlusion Device Societal Overview: The Surgeon's Comment.. 67. 2016
Atrioventricular valve annular remodeling with a bioabsorbable ring in young children.. 60. 2012
President's page: the ACC reconfirms commitment to transparent relationships with industry.. 56. 2010
President's page: imaging: not a black and white issue.. 45. 2005
President's page: the promise of prevention: so, why aren't all cardiologists "preventive"?. 44. 2004
President's page: Exercise your vote: Health care central to election 2004.. 44. 2004
President's page: the appropriate cardiologist: responsible stewardship in a golden era of cardiology.. 44. 2004
President's page: ACC's continuing education programs: setting up systems to meet members' changing needs.. 44. 2004
President's page: Strategic framework: How does the ACC meet its members' needs? Demonstrating how college processes generate organizational plans and decisions.. 43. 2004
Selective ablation of slow atrioventricular node conduction pathways: how safe is the anatomic posterior approach?. 28. 1996
The privilege of self-regulation: the role of appropriate use criteria. 2011
Reply: Understanding Disparities in Coronary Artery Bypass Surgery Outcomes. 2024
Reply: Initial Medical Therapy for Stable Coronary Artery Disease: Until Death Do Us Part. 2024
Temporal Trends in Gender of Principal Investigators and Patients in Cardiovascular Clinical Trials. 2023
Elevated C-Reactive Protein Amplifies Association of Lipoprotein(a) With Cardiovascular Risk and Clinical Benefit of Alirocumab. 2022
Urban-Rural Trends in Young Stroke-Related Mortality in the United States, 1999-2019. 2022
Implications of Biomarker Discordance After Coronary Artery Revascularization: The EXCEL Trial. 2021
Reply: Reliable Diagnosis of Hypertension: What Is the Best Approach? 2021
Reply: Delivering Ethnic and Racial Diversity in Cardiac Imaging Studies of COVID-19 Patients. 2021
Reply: Survival and RV Function After Surgical Management of Acute PE. 2020
Surgeons' Coronary Bypass Practice Patterns in the United States. 2020
Effects of the COVID-19 Pandemic on Active Non-COVID Clinical Trials. 2020
Effect of Baseline Anemia on Outcomes After Left Main Coronary Revascularization. 2020
Decade-Long Temporal Trends in U.S. Hypertension-Related Cardiovascular Mortality. 2020
Reply: Early Mortality Following Catheter Ablation of Atrial Fibrillation. 2020
Sustained Low-Density Lipoprotein Cholesterol Lowering With Alirocumab in ODYSSEY OUTCOMES. 2020
Operator Volume to Outcome Relationship in Mitral and Aortic Valve Replacement. 2019
Asymptomatic Patients With Abnormal Fractional Flow Reserve Treated With Medication Alone or With PCI. 2019
Cardiovascular Biomarkers After Metabolic Surgery Versus Medical Therapy for Diabetes. 2019
Impact of Sleep Duration and Race on Recurrent Cardiovascular Events Following Acute Coronary Syndrome. 2018
ABIM/ACC Competency-Based Education Pilot in Internal Medicine and Cardiovascular Disease. 2017
Telomerase mRNA Reverses Senescence in Progeria Cells. 2017
Reply: Characteristic Left Ventricular Regional Wall Motion Abnormality Can Help Prevent Unnecessary Ischemic Workup. 2017
Objectively Measured Adherence to Physical Activity Guidelines After Acute Coronary Syndrome. 2017
Reply: A Distinct Cardiomyopathy: HCN4 Syndrome Comprising Myocardial Noncompaction, Bradycardia, Mitral Valve Defects, and Aortic Dilation. 2017
Reply: TAVR: Risk Models, Mortality Scoring, and Geriatric Assessment. 2017
Reply: Routine Ischemic Work-Up for Patients With New-Onset Heart Failure. 2017
¹⁸F-Sodium Fluoride PET/MR for the Assessment of Cardiac Amyloidosis. 2016
Reply: Acute Radial Artery Injury After Instrumentation: Are Instrumented Radial Artery Conduits Ideal for CABG? 2016
Cardio-Oncology: The Carney Complex Type I. 2016
"Off-Hours" Versus "On-Hours" Presentation in ST-Segment Elevation Myocardial Infarction: CHAMPION PHOENIX Findings. 2016
Reply: CABG Versus PCI: Are All Revascularization Strategies Created Equal? 2016
Investigator-Reported Bleeding Versus Post Hoc Adjudication of Bleeding: Lessons From the CHAMPION PHOENIX Trial. 2016
Ambulatory Blood Pressure Control and Subclinical Left Ventricular Dysfunction in Treated Hypertensive Subjects. 2015
Left atrial thrombus formation after successful left atrial appendage ligation: case series from a nationwide survey. 2015
Reply: Differences in experience with a new delivery device for LAA ligation among various U.S. centers. 2015
Functional 3D printed patient-specific modeling of severe aortic stenosis. 2014
Reply: Ejection fraction may improve but the scar still exists! The risk may be lower but not zero. 2014
Regarding the effect of dabigatran plasma concentrations. 2014
Left bundle branch block in non-ST-segment elevation acute coronary syndromes. Incidence, angiographic characteristics, and clinical outcomes. 2013
Prevalence of J-point elevation in families with sudden arrhythmic death syndrome. 2012
Is appropriate use criteria for cardiac radionuclide imaging in asymptomatic diabetic patients evidence based? 2010
Is computed tomographic angiography prognostic in patients with cardiac symptoms? 2008
Assessing risk after acute myocardial infarction. 2007
Left ventricular systolic dysfunction in rheumatoid disease. 2006
Black pearl in the LIFE study: angiotensin-II receptor blockade on atrial fibrillation for future personalized medicine. 2005
Association of smoking with improved myocardial perfusion and the angiographic characterization of myocardial tissue perfusion after fibrinolytic therapy for ST-segment elevation myocardial infarction. 2005
Coumadin and the St. Jude valve prosthesis. 1989
Renovascular disease in the elderly. 1986
Quality of care reigns supreme: cardiologists at the helm. 2005
One Step Closer to Unlocking Preeclampsia Prevention.. 85. 2025
Preoperative Telerehabilitation Improves Outcomes After Cardiac Surgery.. 85. 2025
Stable Coronary Artery Disease in the Age of Geriatric Cardiology.. 81. 2023
Drug-Coated Balloons in Peripheral Vascular Interventions: Leave No Trace and Walk Away?. 81. 2023
On-Treatment Hypertension Control in a Real-World Cohort: Lower Blood Pressure Remains Better.. 78. 2021
Bioprosthesis Failure: Is Calcification the Only Problem?. 76. 2020
Cardiology Practice and Training Post-COVID-19: Achieving "Normalcy" After Disruption.. 76. 2020
Framingham General Cardiovascular Risk Score and Cognitive Impairment: The Power of Foresight.. 75. 2020
Blood Pressure Ups and Downs Foreshadow Cerebral Microangiopathy.. 75. 2020
Aortic Dissection Risk in Marfan Syndrome.. 75. 2020
Statins and Cognitive Impairment: Not a Culprit, Protective in Some?. 74. 2019
Application of Transcatheter Repair to Tricuspid Regurgitation: Still Looking Through a Dark Glass.. 73. 2019
Cardiac Magnetic Resonance and Cardio-Oncology: Does T₂ Signal the End of Anthracycline Cardiotoxicity?. 73. 2019
Time to Get Going on Involving FITs in Clinical Trials.. 72. 2018
Novel Markers for Adverse Events in Atrial Fibrillation.. 72. 2018
Additional Arterial Conduits in Coronary Artery Bypass Surgery: Finally Coming of Age.. 71. 2018
Device Closure of Patent Foramen Ovale in Patients With Cryptogenic Stroke: The Tide Has Turned.. 71. 2018
Sham-Controlled Trials for Coronary Interventions: Ethically Acceptable and Ethically Important.. 71. 2018
Diabetes Status and Graft Patency After Coronary Bypass Surgery: Is There a Diabetes Paradox?. 70. 2017
Once More Unto the Breach: A New Treatment Paradigm for Protein-Losing Enteropathy.. 69. 2017
Bleeding and Mortality With Dual Antiplatelet Therapy: The Rashomon Effect.. 69. 2017
Aortic Valve Surgery for Aortic Regurgitation: The Threshold Is Falling.. 68. 2016
Validation of the Bleeding Academic Research Consortium Bleeding Definition: Towards a Standardized Bleeding Score.. 67. 2016
The Future From the Past: A Chance for Change.. 67. 2016
Integrated Measure for Atherogenic Lipoproteins in the Modern Era: Risk Assessment Based on Apolipoprotein B.. 67. 2016
The Role of Peer Support in Attaining Ideal Cardiovascular Health: Peer Pressure and Prevention.. 67. 2015
Team-Based Care and Quality: A Move Toward Evidence-Based Policy.. 66. 2015
Ischemic mitral regurgitation: is mitral valve physiology moving from global to local?. 64. 2014
Calculating risks and benefits to help guide revascularization decisions: turning all available data into useful information.. 64. 2014
Structural and functional cardiac changes are target organ damage that increases risk of atrial fibrillation.. 63. 2014
Antithrombotic regimens in patients with atrial fibrillation and coronary disease: optimizing efficacy and safety.. 62. 2013
Can polymorphisms predict response to antiarrhythmic drugs in atrial fibrillation?. 60. 2012
BOLD new directions in myocardial ischemia imaging-myocardial oxygenation assessment by cardiac magnetic resonance.. 59. 2012
Extra-aortic identifiers to guide genetic testing in familial thoracic aortic aneurysms and dissections syndromes: it is all about the company one keeps.. 60. 2012
Rhythm control for atrial fibrillation favorable outcomes or futile endeavor?. 58. 2011
American industry and the U.S. Cardiovascular Clinical Research Enterprise an appropriate analogy?. 58. 2011
Patients with congenitally corrected transposition of the great arteries and systemic tricuspid valve regurgitation should be referred for surgical consultation as soon as the diagnosis of regurgitation is made.. 57. 2011
Metaiodobenzylguanidine imaging comes of age. A new arrow in the prognostic quiver for heart failure patients.. 55. 2010
Balloon pulmonary valvuloplasty, pulmonary regurgitation, and exercise capacity the good, the bad, and the not yet clear.. 55. 2010
Atrial fibrillation, maybe it is not so lone?. 53. 2009
Critical determinants of limb ischemia.. 52. 2008
Repair of the congenitally bicuspid regurgitant aortic valve: a strategic advance.. 52. 2008
Defining and utilizing surrogates in the evaluation of coronary stents: what do we really want and need to know?. 51. 2008
Computed tomography coronary angiography as an anatomic basis for risk stratification: déjà vu or something new?. 50. 2007
Late ischemic events after clopidogrel cessation following drug-eluting stenting: should we be worried?. 48. 2006
President's page: New York 1952 to Atlanta 2006: celebrating the cardiovascular community.. 47. 2005
President's page: appropriateness criteria: breaking new ground.. 46. 2005
President's page: The practice of medicine: many hands, light work.. 44. 2004
President's page: The trust imperative: ethical choice always puts patient first.. 44. 2004
President's page: Cardiology without borders: embracing a healthy global association.. 44. 2004
Left ventricular hypertrophy in hypertrophic cardiomyopathy: what's in a phenotype?. 44. 2004
President's page: Strengthening our house of cardiology.. 43. 2004
Convocation address: put your heart into ACC fellowship: a vision for growth and achievement.. 43. 2004
QT interval prolongation and prognosis: further validation of the quantitative approach to electrocardiography.. 43. 2004
Cardiac enzyme elevations after percutaneous coronary intervention: myonecrosis, the coronary microcirculation and mortality.. 35. 2000
The decision for revascularization in the 1990s: between a rock and an expert panel.. 29. 1997
Left ventricular geometry, pathophysiology and prognosis.. 25. 1995
Heart rate adjustment of ST segment depression: is the glass half empty or half full?. 19. 1992
Tilt table for the investigation of syncope: there is nothing simple about fainting.. 17. 1991
Toward a more complete understanding of left ventricular afterload.. 17. 1991
NHLBI-CMREF Workshop Report on Pulmonary Vascular Disease Classification: JACC State-of-the-Art Review. 2021
Post-Stroke Cardiovascular Complications and Neurogenic Cardiac Injury: JACC State-of-the-Art Review. 2020
Focused Transesophageal Echocardiography During Cardiac Arrest Resuscitation: JACC Review Topic of the Week. 2020
Alzheimer's Disease and Vascular Aging: JACC Focus Seminar. 2020
Vascular Cognitive Impairment and Dementia: JACC Scientific Expert Panel. 2019
Status of Early-Career Academic Cardiology: A Global Perspective. 2017
Cardiovascular Effects of Exposure to Cigarette Smoke and Electronic Cigarettes: Clinical Perspectives From the Prevention of Cardiovascular Disease Section Leadership Council and Early Career Councils of the American College of Cardiology. 2015
Headed in the right direction but at risk for miscalculation: a critical appraisal of the 2013 ACC/AHA risk assessment guidelines. 2014
Prevention of torsade de pointes in hospital settings: a scientific statement from the American Heart Association and the American College of Cardiology Foundation. 2010
Resting heart rate in cardiovascular disease. 2007
Cardiac arrhythmias. 2006
Assessing low levels of high-density lipoprotein cholesterol as a risk factor in coronary heart disease: a working group report and update. 2004
Antioxidants, statins, and atherosclerosis. 2003
Tricuspid Valve Academic Research Consortium-2 (TVARC-2) Tricuspid Valve: Trial Design and Endpoints. 2026
Aortic Valve Replacement vs Clinical Surveillance in Asymptomatic Severe Aortic Stenosis: A Systematic Review and Meta-Analysis. 2024
Bivalirudin vs Heparin Anticoagulation in STEMI: Confirmation of the BRIGHT-4 Results. 2024
Antithrombotic Therapy for Patients Undergoing Cardiac Electrophysiological and Interventional Procedures: JACC State-of-the-Art Review. 2024
Disparities in Diagnosis, Treatment, and Outcomes of Peripheral Artery Disease: JACC Scientific Statement. 2023
Tricuspid Valve Academic Research Consortium Definitions for Tricuspid Regurgitation and Trial Endpoints. 2023
Recurrent Events in Cardiovascular Trials: JACC State-of-the-Art Review. 2023
Comprehensive Management of ANOCA, Part 1-Definition, Patient Population, and Diagnosis: JACC State-of-the-Art Review. 2023
Comprehensive Management of ANOCA, Part 2-Program Development, Treatment, and Research Initiatives: JACC State-of-the-Art Review. 2023
Sex Differences in Thoracic Aortic Disease and Dissection: JACC Review Topic of the Week. 2023
ACC/AHA and ESC/EACTS Guidelines for the Management of Valvular Heart Diseases: JACC Guideline Comparison. 2023
Risk of Arrhythmic Death in Patients With Nonischemic Cardiomyopathy: JACC Review Topic of the Week. 2023
Combined Minimally Invasive Surgical and Percutaneous Catheter Ablation of Atrial Fibrillation: JACC Review Topic of the Week. 2023
Research Opportunities in the Treatment of Mitral Valve Prolapse: JACC Expert Panel. 2022
A Practical Approach to Left Main Coronary Artery Disease: JACC State-of-the-Art Review. 2022
Coronary Artery Bypass Surgery Without Saphenous Vein Grafting: JACC Review Topic of the Week. 2022
Bioprosthetic Aortic Valve Hemodynamics: Definitions, Outcomes, and Evidence Gaps: JACC State-of-the-Art Review. 2022
Pericardial Effusion Provoking Atrial Fibrillation After Cardiac Surgery: JACC Review Topic of the Week. 2022
Sex-Related Outcomes of Medical, Percutaneous, and Surgical Interventions for Coronary Artery Disease: JACC Focus Seminar 3/7. 2022
Global Chronic Total Occlusion Crossing Algorithm: JACC State-of-the-Art Review. 2021
Improving Terminology to Describe Coronary Artery Procedures: JACC Review Topic of the Week. 2021
Cardiovascular Risk in Patients With Psoriasis: JACC Review Topic of the Week. 2021
Gerotechnology for Older Adults With Cardiovascular Diseases: JACC State-of-the-Art Review. 2020
Randomized Trials Versus Common Sense and Clinical Observation: JACC Review Topic of the Week. 2020
Randomized Trials in Cardiac Surgery: JACC Review Topic of the Week. 2020
10 Recommendations to Enhance Recruitment, Retention, and Career Advancement of Women Cardiologists. 2019
Clonal Hematopoiesis: Crossroads of Aging, Cardiovascular Disease, and Cancer: JACC Review Topic of the Week. 2019
Deprescribing in Older Adults With Cardiovascular Disease. 2019
Cardiac Phenotypes in Hereditary Muscle Disorders: JACC State-of-the-Art Review. 2018
Mobile Health Advances in Physical Activity, Fitness, and Atrial Fibrillation: Moving Hearts. 2018
Using Digital Health Technology to Better Generate Evidence and Deliver Evidence-Based Care. 2018
Domain Management Approach to Heart Failure in the Geriatric Patient: Present and Future. 2018
The Radial Artery for Percutaneous Coronary Procedures or Surgery? 2018
ACC Appropriate Use Criteria Methodology: 2018 Update: A Report of the American College of Cardiology Appropriate Use Criteria Task Force. 2018
Improving Heart Failure Therapeutics Development in the United States: The Heart Failure Collaboratory. 2018
Role of Payers in the Development of Cardiovascular Therapeutics: Misalignment Between Approval and Reimbursement. 2017
Clinical Trial Principles and Endpoint Definitions for Paravalvular Leaks in Surgical Prosthesis: An Expert Statement. 2017
Potent P2Y₁₂ Inhibitors in Men Versus Women: A Collaborative Meta-Analysis of Randomized Trials. 2017
The Academic Medical System: Reinvention to Survive the Revolution in Health Care. 2017
The Changing Landscape of Randomized Clinical Trials in Cardiovascular Disease. 2016
Left Ventricular Noncompaction: A Distinct Genetic Cardiomyopathy? 2016
Cardiovascular Effects of the New Weight Loss Agents. 2016
Natural History, Diagnostic Approaches, and Therapeutic Strategies for Patients With Asymptomatic Severe Aortic Stenosis. 2016
Medical Therapy With Versus Without Revascularization in Stable Patients With Moderate and Severe Ischemia: The Case for Community Equipoise. 2015
The Choice of Conduits in Coronary Artery Bypass Surgery. 2015
Transcatheter Therapies for the Treatment of Valvular and Paravalvular Regurgitation in Acquired and Congenital Valvular Heart Disease. 2015
Finding the Gatekeeper to the Cardiac Catheterization Laboratory: Coronary CT Angiography or Stress Testing? 2015
Left Atrial Appendage Closure as an Alternative to Warfarin for Stroke Prevention in Atrial Fibrillation: A Patient-Level Meta-Analysis. 2015
COCATS 4 Task Force 15: Training in Cardiovascular Research and Scholarly Activity. 2015
The future of clinical research and the ACC: empowerment through registries, data, and our members. 2014
Radial versus femoral access. 2013
Pre- and post-operative diastolic dysfunction in patients with valvular heart disease: diagnosis and therapeutic implications. 2013
Cardiac troponin after percutaneous coronary intervention and 1-year mortality in non-ST-segment elevation acute coronary syndrome using systematic evaluation of biomarker trends. 2013
2013 appropriate utilization of cardiovascular imaging: a methodology for the development of joint criteria for the appropriate utilization of cardiovascular imaging by the American College of Cardiology Foundation and American College of Radiology. 2013
Impact of the everolimus-eluting stent on stent thrombosis: a meta-analysis of 13 randomized trials. 2011
Prevention of atrial fibrillation by Renin-Angiotensin system inhibition a meta-analysis. 2010
Biomarkers of peripheral arterial disease. 2010
Antithrombotics in acute coronary syndromes. 2009
Cardiogenic and aortogenic brain embolism. 2008
Insights into degenerative aortic valve disease. 2007
Noninvasive cardiac imaging in patients with hypertrophic cardiomyopathy. 2006
Systolic and diastolic dyssynchrony in patients with diastolic heart failure and the effect of medical therapy. 2006
Rationale and strategies for implementing community-based transfer protocols for primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction. 2004
34th Bethesda Conference: Task force #3--What is the spectrum of current and emerging techniques for the noninvasive measurement of atherosclerosis? 2003
Risks and benefits of adding anti-platelet therapy to warfarin among patients with prosthetic heart valves: a meta-analysis. 2001
Shifting the open-artery hypothesis downstream: the quest for optimal reperfusion. 2001
Platelet glycoprotein IIb/IIIa blockade and outcome of cardiogenic shock complicating acute coronary syndromes without persistent ST-segment elevation. 2000
Phytoestrogens and cardiovascular health. 2000
Myonecrosis after revascularization procedures. 1998
Percutaneous revascularization of chronic coronary occlusions: an overview. 1995
Heart rate adjustment of ST segment depression and performance of the exercise electrocardiogram: a critical evaluation. 1995
Remodeling and reparation of the cardiovascular system. 1992
A paradigm for restenosis based on cell biology: clues for the development of new preventive therapies. 1991
2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. 2026
2026 AHA/ACC/ACCP/ACEP/CHEST/SCAI/SHM/SIR/SVM/SVN Guideline for the Evaluation and Management of Acute Pulmonary Embolism in Adults: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. 2026
2026 ACC/AHA Clinical Performance and Quality Measures for Patients With Peripheral Artery Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Performance Measures. 2026
HRS/ACC Scientific Statement: Guiding Principles on the Performance of Intracardiac Ablation Procedures in Ambulatory Surgical Centers. 2025
2025 Concise Clinical Guidance: An ACC Expert Consensus Statement on Medical Weight Management for Optimization of Cardiovascular Health: A Report of the American College of Cardiology Solution Set Oversight Committee. 2025
2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. 2025
ACC/AHA/ASE/HFSA/HRS/SCAI/SCCT/SCMR 2025 Appropriate Use Criteria for Implantable Cardioverter-Defibrillators, Cardiac Resynchronization Therapy, and Pacing. 2025
ACC/AHA/ASE/ASNC/HFSA/HRS/SCAI/SCCT/SCMR/STS 2024 Appropriate Use Criteria for Multimodality Imaging in Cardiovascular Evaluation of Patients Undergoing Nonemergent, Noncardiac Surgery. 2024
2024 ACC/AHA/AACVPR/APMA/ABC/SCAI/SVM/SVN/SVS/SIR/VESS Guideline for the Management of Lower Extremity Peripheral Artery Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. 2024
2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. 2021
2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. 2021
Taking a Stand Against Air Pollution-The Impact on Cardiovascular Disease: A Joint Opinion from the World Heart Federation, American College of Cardiology, American Heart Association, and the European Society of Cardiology. 2021
Safe Reintroduction of Cardiovascular Services During the COVID-19 Pandemic: From the North American Society Leadership. 2020
Considerations for Drug Interactions on QTc Interval in Exploratory COVID-19 Treatment. 2020
ACCF/AHA/ASE/ASNC/HFSA/HRS/SCAI/SCCT/SCMR/STS 2013 multimodality appropriate use criteria for the detection and risk assessment of stable ischemic heart disease: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, and Society of Thoracic Surgeons. 2013
ACCF/ACR/AIUM/ASE/ASN/ICAVL/SCAI/SCCT/SIR/SVM/SVS/SVU [corrected] 2012 appropriate use criteria for peripheral vascular ultrasound and physiological testing part I: arterial ultrasound and physiological testing: a report of the American College of Cardiology Foundation appropriate use criteria task force, American College of Radiology, American Institute of Ultrasound in Medicine, American Society of Echocardiography, American Society of Nephrology, Intersocietal Commission for the Accreditation of Vascular Laboratories, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, Society for Interventional Radiology, Society for Vascular Medicine, Society for Vascular Surgery, [corrected] and Society for Vascular Ultrasound. [corrected]. 2012
ACCF/SCAI/STS/AATS/AHA/ASNC/HFSA/SCCT 2012 Appropriate use criteria for coronary revascularization focused update: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, Society for Cardiovascular Angiography and Interventions, Society of Thoracic Surgeons, American Association for Thoracic Surgery, American Heart Association, American Society of Nuclear Cardiology, and the Society of Cardiovascular Computed Tomography. 2012
ACCF/ASE/AHA/ASNC/HFSA/HRS/SCAI/SCCM/SCCT/SCMR 2011 Appropriate Use Criteria for Echocardiography. A Report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, American Society of Echocardiography, American Heart Association, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, Society of Critical Care Medicine, Society of Cardiovascular Computed Tomography, and Society for Cardiovascular Magnetic Resonance Endorsed by the American College of Chest Physicians. 2011
ACCF/SCCT/ACR/AHA/ASE/ASNC/NASCI/SCAI/SCMR 2010 appropriate use criteria for cardiac computed tomography. A report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, the Society of Cardiovascular Computed Tomography, the American College of Radiology, the American Heart Association, the American Society of Echocardiography, the American Society of Nuclear Cardiology, the North American Society for Cardiovascular Imaging, the Society for Cardiovascular Angiography and Interventions, and the Society for Cardiovascular Magnetic Resonance. 2010
Management of platelet-directed pharmacotherapy in patients with atherosclerotic coronary artery disease undergoing elective endoscopic gastrointestinal procedures. 2009
AHA/ACCF/HRS recommendations for the standardization and interpretation of the electrocardiogram: part III: intraventricular conduction disturbances: a scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society. Endorsed by the International Society for Computerized Electrocardiology. 2009
AHA/ACCF/HRS recommendations for the standardization and interpretation of the electrocardiogram: part IV: the ST segment, T and U waves, and the QT interval: a scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society. Endorsed by the International Society for Computerized Electrocardiology. 2009
AHA/ACCF/HRS recommendations for the standardization and interpretation of the electrocardiogram: part V: electrocardiogram changes associated with cardiac chamber hypertrophy: a scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society. Endorsed by the International Society for Computerized Electrocardiology. 2009
AHA/ACCF/HRS recommendations for the standardization and interpretation of the electrocardiogram: part VI: acute ischemia/infarction: a scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society. Endorsed by the International Society for Computerized Electrocardiology. 2009
ACCF/ASE/ACEP/AHA/ASNC/SCAI/SCCT/SCMR 2008 appropriateness criteria for stress echocardiography: a report of the American College of Cardiology Foundation Appropriateness Criteria Task Force, American Society of Echocardiography, American College of Emergency Physicians, American Heart Association, American Society of Nuclear Cardiology, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and Society for Cardiovascular Magnetic Resonance endorsed by the Heart Rhythm Society and the Society of Critical Care Medicine. 2008
Task force 11: training in vascular medicine and peripheral vascular catheter-based interventions endorsed by the Society for Cardiovascular Angiography and Interventions and the Society for Vascular Medicine. 2008
ACCF/ASE/ACEP/ASNC/SCAI/SCCT/SCMR 2007 appropriateness criteria for transthoracic and transesophageal echocardiography: a report of the American College of Cardiology Foundation Quality Strategic Directions Committee Appropriateness Criteria Working Group, American Society of Echocardiography, American College of Emergency Physicians, American Society of Nuclear Cardiology, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and the Society for Cardiovascular Magnetic Resonance endorsed by the American College of Chest Physicians and the Society of Critical Care Medicine. 2007
Recommendations for the standardization and interpretation of the electrocardiogram: part I: the electrocardiogram and its technology a scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society endorsed by the International Society for Computerized Electrocardiology. 2007
Recommendations for the standardization and interpretation of the electrocardiogram: part II: electrocardiography diagnostic statement list a scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society Endorsed by the International Society for Computerized Electrocardiology. 2007
ACCF/ACR/SCCT/SCMR/ASNC/NASCI/SCAI/SIR 2006 appropriateness criteria for cardiac computed tomography and cardiac magnetic resonance imaging: a report of the American College of Cardiology Foundation Quality Strategic Directions Committee Appropriateness Criteria Working Group, American College of Radiology, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, American Society of Nuclear Cardiology, North American Society for Cardiac Imaging, Society for Cardiovascular Angiography and Interventions, and Society of Interventional Radiology. 2006
ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death). 2006
ACCF proposed method for evaluating the appropriateness of cardiovascular imaging. 2005
ACCF/ASNC appropriateness criteria for single-photon emission computed tomography myocardial perfusion imaging (SPECT MPI): a report of the American College of Cardiology Foundation Quality Strategic Directions Committee Appropriateness Criteria Working Group and the American Society of Nuclear Cardiology endorsed by the American Heart Association. 2005
ACC/AHA clinical competence statement on echocardiography: a report of the American College of Cardiology/American Heart Association/American College of Physicians-American Society of Internal Medicine Task Force on Clinical Competence. 2003
American College of Cardiology/American Heart Association Clinical Competence statement on stress testing: a report of the American College of Cardiology/American Heart Association/American College of Physicians--American Society of Internal Medicine Task Force on Clinical Competence. 2000
Recommendations for the assessment and maintenance of proficiency in coronary interventional procedures: Statement of the American College of Cardiology. 1998

VIVO Weill Cornell Medical College

Journal of the American College of Cardiology Journal

Overview

publication venue for

Identity

ISO Abbreviation

Linking ISSN

International Standard Serial Number (ISSN)

Electronic International Standard Serial Number (EISSN)